forecast

R&D is all development on a single mechanism

The company is no longer doing basic research but only development, applying one mechanism of action that has worked across 20 to 30 cell lines and every animal model and first-in-human study, so trial size is set to grow 20 to 30 times.

forecastpending

Speaker

Bill

Evidence Quote

“the N is 20 to 30 times where we are today”

Source

Novocure: Using Physics to Fight Cancer— Business Breakdowns
Created: 11/19/2026, 2:27:17 AM

Your notes

Loading notes...